Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder
- PMID: 40426603
- PMCID: PMC12109660
- DOI: 10.3390/brainsci15050430
Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder
Abstract
Background/objectives: Precision medicine is not just hype. Instead, it represents a high bar for developing more effective, safer, and better-tolerated therapies in medicine, without exception in psychiatry, including bipolar disorder (BD). A burgeoning body of narrative reviews and perspective papers has already appraised the boundaries of precision medicine in BD.
Methods: This brief perspective follows a narrative, critical approach focusing explicitly on the antipsychotic management of BD using precision approaches.
Results: While most controversies align with those previously appraised in BD's overall precision medicine approach, specific insights are provided herein.
Conclusions: Beyond other implications and the strengthened call for valid diagnostic coding systems, the implementation of shared decision-making tools and pharmacogenomics studies focusing on persons with BD are particularly warranted.
Keywords: antipsychotic; bipolar disorder; precision medicine; psychopharmacology; shared decision-making.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Yager J., Feinstein R.E. Potential applications of the National Institute of Mental Health’s Research Domain Criteria (RDoC) to clinical psychiatric practice: How RDoC might be used in assessment, diagnostic processes, case formulation, treatment planning, and clinical notes. J. Clin. Psychiatry. 2017;78:1239. doi: 10.4088/JCP.15nr10476. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous